BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 14519955)

  • 1. Intradermal delivery of antisense oligonucleotides by the pulse depolarization iontophoretic system.
    Aramaki Y; Arima H; Takahashi M; Miyazaki E; Sakamoto T; Tsuchiya S
    Biol Pharm Bull; 2003 Oct; 26(10):1461-6. PubMed ID: 14519955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
    Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
    Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation into the potential of iontophoresis facilitated delivery of ketorolac.
    Tiwari SB; Udupa N
    Int J Pharm; 2003 Jul; 260(1):93-103. PubMed ID: 12818814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient intradermal delivery of superoxide dismutase using a combination of liposomes and iontophoresis for protection against UV-induced skin damage.
    Kigasawa K; Miyashita M; Kajimoto K; Kanamura K; Harashima H; Kogure K
    Biol Pharm Bull; 2012; 35(5):781-5. PubMed ID: 22687417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of size and sequence on the iontophoretic delivery of oligonucleotides.
    Brand RM; Wahl A; Iversen PL
    J Pharm Sci; 1998 Jan; 87(1):49-52. PubMed ID: 9452967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermal/transdermal delivery of small interfering RNA and antisense oligonucleotides- advances and hurdles.
    Ita K
    Biomed Pharmacother; 2017 Mar; 87():311-320. PubMed ID: 28064104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iontophoretic transdermal delivery of glycyrrhizin: effects of pH, drug concentration, co-ions, current intensity, and chemical enhancers.
    Yamamoto R; Takasuga S; Kominami K; Sutoh C; Kinoshita M; Kanamura K; Takayama K
    Chem Pharm Bull (Tokyo); 2013; 61(12):1275-81. PubMed ID: 24292789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effect of iontophoresis and soluble microneedles for transdermal delivery of methotrexate.
    Vemulapalli V; Yang Y; Friden PM; Banga AK
    J Pharm Pharmacol; 2008 Jan; 60(1):27-33. PubMed ID: 18088502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential use of iontophoresis for transdermal delivery of NF-kappaB decoy oligonucleotides.
    Hashim II; Motoyama K; Abd-Elgawad AE; El-Shabouri MH; Borg TM; Arima H
    Int J Pharm; 2010 Jun; 393(1-2):127-34. PubMed ID: 20417264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iontophoretic delivery of oligonucleotides across full thickness hairless mouse skin.
    Oldenburg KR; Vo KT; Smith GA; Selick HE
    J Pharm Sci; 1995 Aug; 84(8):915-21. PubMed ID: 7500273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transport mechanisms in iontophoresis. III. An experimental study of the contributions of electroosmotic flow and permeability change in transport of low and high molecular weight solutes.
    Pikal MJ; Shah S
    Pharm Res; 1990 Mar; 7(3):222-9. PubMed ID: 2339093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal delivery of antisense oligonucleotides with microprojection patch (Macroflux) technology.
    Lin W; Cormier M; Samiee A; Griffin A; Johnson B; Teng CL; Hardee GE; Daddona PE
    Pharm Res; 2001 Dec; 18(12):1789-93. PubMed ID: 11785702
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhanced transdermal delivery of AZT (Zidovudine) using iontophoresis and penetration enhancer.
    Oh SY; Jeong SY; Park TG; Lee JH
    J Control Release; 1998 Feb; 51(2-3):161-8. PubMed ID: 9685913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms involved in iontophoretic transport of angiotensin.
    Clemessy M; Couarraze G; Bevan B; Puisieux F
    Pharm Res; 1995 Jul; 12(7):998-1002. PubMed ID: 7494820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iontophoretic delivery of a telomeric oligonucleotide.
    Brand RM; Iversen PL
    Pharm Res; 1996 Jun; 13(6):851-4. PubMed ID: 8792421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of electroporation on the electroosmosis across hairless mouse skin in vitro.
    Tokumoto S; Mori K; Higo N; Sugibayashi K
    J Control Release; 2005 Jul; 105(3):296-304. PubMed ID: 15894395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal iontophoresis of hydromorphone across hairless rat skin in vitro.
    Kumar MG; Lin S
    Pharm Dev Technol; 2009; 14(1):106-15. PubMed ID: 18825546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal iontophoretic drug delivery: advances and challenges.
    Ita K
    J Drug Target; 2016; 24(5):386-91. PubMed ID: 26406291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal iontophoretic delivery of propofol: a general anaesthetic in the form of its phosphate salt.
    Juluri A; Peddikotla P; Repka MA; Murthy SN
    J Pharm Sci; 2013 Feb; 102(2):500-7. PubMed ID: 23175436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.